Global Liver Institute’s Statement on Centers for Medicare & Medicaid Services Obesity Coverage Proposed Rule
Global Liver Institute is thrilled to share that the Centers for Medicare & Medicaid Services (CMS) has proposed to align coverage policy to reflect the understanding that obesity is a chronic disease.
Healthy Holidays! Gut Friendly Tips and Liver Health Innovations – Liver Cancer News
Welcome back to this special holiday edition of Liver Cancer News! As the festive season begins, read on to discover articles on liver cancer health, the latest management tools, and recent innovations.
Global Liver Institute Acknowledges FDA Request for Further Studies as Obeticholic Acid Remains Available for PBC Patients
Global Liver Institute (GLI) acknowledges the U.S. Food and Drug Administration’s (FDA) decision today to issue a Complete Response Letter (CRL) for the supplemental New Drug Application (sNDA) of obeticholic acid (OCA, OCALIVA®) for primary biliary cholangitis (PBC).
After elections, a lame-duck Congress will need to pass appropriations bills and hopefully “clear the decks” by passing long-awaited health reforms – Liver Health Policy Update
Members of Congress will return to Washington, DC, after the elections. Hopes remain for a productive November legislative session where some legislative priorities may finally make it to final passage.
Uniting for Equity in Liver Cancer Care – Liver Cancer News
In October, Global Liver Institute led its annual #OctoberIs4Livers campaign, focused on health equity and raising awareness about liver cancer.